Rhodococcus ruber Cell Wall Components for Thermal Injury Treatment
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current applications of Rhodococcus ruber are limited to environmental management, with no reported use in human medicine for treating thermal injuries, such as burns or scalds, despite its potential as an immune adjuvant and organic compound degrader.
Innovation Solution
Isolation and use of Rhodococcus ruber cell wall components, including proteins, nucleic acids, lipids, and carbohydrates, in pharmaceutical compositions and medical devices for treating thermal injuries, with formulations such as ointments, creams, and dressings, to promote wound healing.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Adaptability or versatility
If Rhodococcus ruber is used as an immune adjuvant in animal vaccines, then antibody production is promoted, but there is no reported application in human medicine for treating thermal injuries
Solution Approach 1:
The patent applies the universality principle by demonstrating that Rhodococcus ruber cell wall components can serve multiple functions: acting as an immune adjuvant in animal vaccines and simultaneously serving as a therapeutic agent for treating thermal injuries in humans. The cell wall components (peptidoglycan, teichoic acid, lipids, proteins) exhibit both immunomodulatory effects and wound healing促进作用, enabling the same biological material to address different medical needs across species boundaries.
2Object-affected harmful factors
If conventional anti-infective therapeutic principles are applied to thermal injuries, then infection control is achieved, but wound healing time is extended and scarring occurs
Solution Approach 1:
The patent applies the 'blessing in disguise' principle by converting the potentially harmful bacterial cell wall components into beneficial therapeutic agents. The cell wall components of Rhodococcus ruber, which are normally structural elements, are utilized to promote wound healing and reduce scarring. The components stimulate the immune system and accelerate tissue regeneration, transforming what could be foreign invaders into allies that facilitate recovery and minimize damage.
Solution Approach 2:
The patent applies parameter changes by modifying the physical and chemical properties of the wound environment through application of Rhodococcus ruber cell wall components. These components alter parameters such as inflammation levels, tissue regeneration rate, and scar formation tendency, thereby accelerating the healing process while maintaining infection control.
3Productivity
If Rhodococcus ruber cell wall components are used in pharmaceutical compositions, then wound healing is enhanced, but formulation complexity increases
Solution Approach 1:
The patent applies the extraction principle by isolating and utilizing specific functional components from the Rhodococcus ruber cell wall, namely peptidoglycan, teichoic acid, lipids, and proteins. By extracting these key active ingredients rather than using the entire bacterial cell or complex crude extracts, the formulation achieves therapeutic efficacy while reducing unnecessary complexity. The extracted components can be incorporated into various pharmaceutical dosage forms (ointments, creams, gels, dressings) with standardized compositions.
Data Source
AI summary
A use of a cell wall or a cell wall skeleton of Rhodococcus ruber in preparing a drug for treating a thermal injury. The thermal injury comprises a burn, a scald and a chemical burn. Applying the Rhodococcus ruber product to a subject has a good therapeutic effect on a thermal injury and has no side effects.